272 related articles for article (PubMed ID: 24127237)
1. Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity.
He Q; Yang X; Gong Y; Kovalenko D; Canalis E; Rosen CJ; Friesel RE
J Bone Miner Res; 2014; 29(5):1217-31. PubMed ID: 24127237
[TBL] [Abstract][Full Text] [Related]
2. Connexin43 and Runx2 Interact to Affect Cortical Bone Geometry, Skeletal Development, and Osteoblast and Osteoclast Function.
Buo AM; Tomlinson RE; Eidelman ER; Chason M; Stains JP
J Bone Miner Res; 2017 Aug; 32(8):1727-1738. PubMed ID: 28419546
[TBL] [Abstract][Full Text] [Related]
3. Loss of Runx2 in committed osteoblasts impairs postnatal skeletogenesis.
Adhami MD; Rashid H; Chen H; Clarke JC; Yang Y; Javed A
J Bone Miner Res; 2015 Jan; 30(1):71-82. PubMed ID: 25079226
[TBL] [Abstract][Full Text] [Related]
4. Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association.
Martin A; Xiong J; Koromila T; Ji JS; Chang S; Song YS; Miller JL; Han CY; Kostenuik P; Krum SA; Chimge NO; Gabet Y; Frenkel B
Bone; 2015 Jun; 75():96-104. PubMed ID: 25701138
[TBL] [Abstract][Full Text] [Related]
5. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
[TBL] [Abstract][Full Text] [Related]
6. Runx2 deletion in hypertrophic chondrocytes impairs osteoclast mediated bone resorption.
Rashid H; Smith CM; Convers V; Clark K; Javed A
Bone; 2024 Apr; 181():117014. PubMed ID: 38218304
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous mutation of Dock7 results in lower trabecular bone mass and impaired periosteal expansion in aged female Misty mice.
Le PT; Bishop KA; Maridas DE; Motyl KJ; Brooks DJ; Nagano K; Baron R; Bouxsein ML; Rosen CJ
Bone; 2017 Dec; 105():103-114. PubMed ID: 28821457
[TBL] [Abstract][Full Text] [Related]
8. Acvr1 deletion in osteoblasts impaired mandibular bone mass through compromised osteoblast differentiation and enhanced sRANKL-induced osteoclastogenesis.
Hu Y; Hao X; Liu C; Ren C; Wang S; Yan G; Meng Y; Mishina Y; Shi C; Sun H
J Cell Physiol; 2021 Jun; 236(6):4580-4591. PubMed ID: 33251612
[TBL] [Abstract][Full Text] [Related]
9. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.
Mukherjee A; Rotwein P
Mol Cell Biol; 2012 Jan; 32(2):490-500. PubMed ID: 22064480
[TBL] [Abstract][Full Text] [Related]
10. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
11. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
12. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.
Geoffroy V; Kneissel M; Fournier B; Boyde A; Matthias P
Mol Cell Biol; 2002 Sep; 22(17):6222-33. PubMed ID: 12167715
[TBL] [Abstract][Full Text] [Related]
13. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells.
Bai S; Kopan R; Zou W; Hilton MJ; Ong CT; Long F; Ross FP; Teitelbaum SL
J Biol Chem; 2008 Mar; 283(10):6509-18. PubMed ID: 18156632
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
15. Microtubule assembly affects bone mass by regulating both osteoblast and osteoclast functions: stathmin deficiency produces an osteopenic phenotype in mice.
Liu H; Zhang R; Ko SY; Oyajobi BO; Papasian CJ; Deng HW; Zhang S; Zhao M
J Bone Miner Res; 2011 Sep; 26(9):2052-67. PubMed ID: 21557310
[TBL] [Abstract][Full Text] [Related]
16. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.
Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A
Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811
[TBL] [Abstract][Full Text] [Related]
17. Runx2 Controls Bone Resorption through the Down-Regulation of the Wnt Pathway in Osteoblasts.
Haxaire C; Haÿ E; Geoffroy V
Am J Pathol; 2016 Jun; 186(6):1598-609. PubMed ID: 27083516
[TBL] [Abstract][Full Text] [Related]
18. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
[TBL] [Abstract][Full Text] [Related]
19. PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling.
Li S; Liu Q; Wu D; He T; Yuan J; Qiu H; Tickner J; Zheng SG; Li X; Xu J; Rong L
Cell Death Dis; 2020 Sep; 11(9):762. PubMed ID: 32938907
[TBL] [Abstract][Full Text] [Related]
20. Discoidin Receptor 2 Controls Bone Formation and Marrow Adipogenesis.
Ge C; Wang Z; Zhao G; Li B; Liao J; Sun H; Franceschi RT
J Bone Miner Res; 2016 Dec; 31(12):2193-2203. PubMed ID: 27341689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
